tiprankstipranks
Interpace Diagnostics Group (IDXG)
OTHER OTC:IDXG
US Market

Interpace Diagnostics Group (IDXG) Income Statement

Compare
410 Followers

Interpace Diagnostics Group Income Statement

Last quarter (Q3 2024), Interpace Diagnostics Group's total revenue was $12.29M, an increase of 35.44% from the same quarter last year. In Q3, Interpace Diagnostics Group's net income was $1.28M. See Interpace Diagnostics Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 40.21M$ 31.84M$ 41.31M$ 32.40M$ 24.08M
Gross Profit
$ 23.90M$ 18.23M$ 17.95M$ 10.72M$ 8.19M
Operating Expenses
$ 21.10M$ 22.07M$ 29.68M$ 37.28M$ 32.12M
Depreciation and Amortization
$ 1.03M$ 2.56M$ 5.37M$ 5.50M$ 4.52M
EBITDA
$ 3.84M$ -2.27M$ -1.33M$ -20.10M$ -21.72M
Operating Income
$ 2.80M$ -3.84M$ -11.74M$ -26.55M$ -23.93M
Other Income/Expenses
$ -1.68M$ -2.22M$ -1.41M$ -82.00K$ -244.00K
Pretax Income
$ 1.13M$ -5.84M$ -15.41M$ -26.15M$ -26.67M
Net Income
$ 802.00K$ -5.87M$ -14.75M$ -26.20M$ -26.64M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.19$ -1.38$ -3.57$ -6.50$ -7.11
Diluted EPS
$ 0.18$ -1.38$ -3.57$ -6.50$ -7.11
Weighted Average Shares Outstanding
4.32M 4.24M 4.13M 4.03M 3.75M
Weighted Average Shares Outstanding (Diluted)
4.36M 4.24M 4.13M 4.03M 3.75M
Currency in USD

Interpace Diagnostics Group Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis